Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer
- PMID: 16299532
- DOI: 10.1038/sj.onc.1209041
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer
Abstract
Reovirus has an inherent preference for replicating in cells with dysregulated growth factor signaling cascades that comprise Ras activation. Precisely how reovirus exploits the host cell Ras pathway is unclear, but there is evidence suggesting that activated Ras signaling is important for efficient viral protein synthesis. Defining the molecular mechanism of reovirus oncolysis will shed light on reovirus replication and important aspects of cellular transformation, Ras signaling cascades and regulation of protein translation.
Similar articles
-
Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.Methods Mol Biol. 2012;797:163-76. doi: 10.1007/978-1-61779-340-0_12. Methods Mol Biol. 2012. PMID: 21948476
-
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.EMBO J. 1998 Jun 15;17(12):3351-62. doi: 10.1093/emboj/17.12.3351. EMBO J. 1998. PMID: 9628872 Free PMC article.
-
Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.Mol Ther. 2007 Aug;15(8):1522-30. doi: 10.1038/sj.mt.6300179. Epub 2007 Apr 24. Mol Ther. 2007. PMID: 17457318
-
Reovirus and tumor oncolysis.J Microbiol. 2007 Jun;45(3):187-92. J Microbiol. 2007. PMID: 17618222 Review.
-
Oncolytic viral therapy using reovirus.Methods Mol Biol. 2009;542:607-34. doi: 10.1007/978-1-59745-561-9_31. Methods Mol Biol. 2009. PMID: 19565924 Review.
Cited by
-
The oncolytic virus, pelareorep, as a novel anticancer agent: a review.Invest New Drugs. 2015 Jun;33(3):761-74. doi: 10.1007/s10637-015-0216-8. Epub 2015 Feb 19. Invest New Drugs. 2015. PMID: 25693885 Review.
-
Oncolytic viruses: how "lytic" must they be for therapeutic efficacy?Oncoimmunology. 2019 Mar 28;8(6):e1581528. doi: 10.1080/2162402X.2019.1596006. eCollection 2019. Oncoimmunology. 2019. PMID: 31069150 Free PMC article. Review.
-
Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells.PLoS One. 2011;6(9):e24809. doi: 10.1371/journal.pone.0024809. Epub 2011 Sep 19. PLoS One. 2011. PMID: 21949758 Free PMC article.
-
Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancer.Breast Cancer Res. 2024 May 15;26(1):78. doi: 10.1186/s13058-024-01818-5. Breast Cancer Res. 2024. PMID: 38750591 Free PMC article.
-
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.Cell Death Dis. 2013 Jul 18;4(7):e728. doi: 10.1038/cddis.2013.259. Cell Death Dis. 2013. PMID: 23868061 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources